The broad focus of the proposed research is to understand how the activation of a resident nonparenchymal liver cell, the lipocyte (also known as Ito or stellate cell) is regulated in hapatic fibrosis and cirrhosis. Studies during the recent funding period have defined the major components of lipocyte activation, which is the transition of lipocytes from resting, vitamin A-rich cells to proliferating, fibrogenic cells with reduced vitamin A content. Activation is common to all forms of fibrosing liver injury and reflects a discrete program of gene expression involving induction of cytokines and their receptors, extracellular matrix molecules, cytoskeletal components, and metalloproteinases. A novel cDNA termed 'Zf9', has been cloned by subtractive hybridization from rat lipocytes activated in vivo. Zf9's cDNA sequence predicts 3 zinc finger domains which are nearly identical to those of the well characterized transcription factor Sp1, but whose serine-rich 5' activation domain is unique. Zf9 is an immediate-early lipocyte gene which is rapidly induced in mechanistically distinct models of liver injury in vivo, and in culture models of activation, but is not detected in a kidney model of fibrosis. The hypothesis is the Zf9 is a lipocyte-specific transcriptional regulator which plays a central role in lipocyte activation and has the biologic properties of other zinc finger transcription proteins.
The Specific Aims are to: 1) Determine the structure and biologic function of Zf9 by a) full length rat cDNA cloning and homology cloning of human Zf9; b) assessing DNA binding; cv) examining transcriptional activity; d) determining if it is phosphorylated; e) evaluating whether its expression confers an activated phenotype on quiescent lipocytes. 2) Establish whether Zf9 is lipocyte- and liver-specific and define its subcellular location. 3) Examine Zf9s regulatory activity for 2 genes (collagen alpha1 (I) and TGFbeta1) whose induction is central to hepatic fibrosis and 4) Identify transcriptional coactivating proteins that complex with Af9 in activated lipocytes. The experiments are a direct extension of previously funded studies exploring the features of lipocyte activation, and are immediately relevant to the pathogenesis of cirrhosis in patients with chronic liver injury and fibrosis. The findings could lead to new treatments for this debilitating and incurable condition.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK037340-11
Application #
2443992
Study Section
Metabolic Pathology Study Section (MEP)
Project Start
1987-01-01
Project End
1997-12-31
Budget Start
1997-07-01
Budget End
1997-12-31
Support Year
11
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Gallardo-Vara, Eunate; Blanco, Francisco J; Roqué, Mercè et al. (2016) Transcription factor KLF6 upregulates expression of metalloprotease MMP14 and subsequent release of soluble endoglin during vascular injury. Angiogenesis 19:155-71
Sawaki, Daigo; Hou, Lianguo; Tomida, Shota et al. (2015) Modulation of cardiac fibrosis by Krüppel-like factor 6 through transcriptional control of thrombospondin 4 in cardiomyocytes. Cardiovasc Res 107:420-30
Son, Bo-Kyung; Sawaki, Daigo; Tomida, Shota et al. (2015) Granulocyte macrophage colony-stimulating factor is required for aortic dissection/intramural haematoma. Nat Commun 6:6994
Lee, Jung Min; Yang, Jing; Newell, Pippa et al. (2014) ?-Catenin signaling in hepatocellular cancer: Implications in inflammation, fibrosis, and proliferation. Cancer Lett 343:90-7
Layden, Jennifer E; Tayo, Bamidele O; Cotler, Scott J et al. (2014) Association of genetic variants with rapid fibrosis: progression after liver transplantation for hepatitis C. Transplantation 97:1072-8
Tsedensodnom, Orkhontuya; Vacaru, Ana M; Howarth, Deanna L et al. (2013) Ethanol metabolism and oxidative stress are required for unfolded protein response activation and steatosis in zebrafish with alcoholic liver disease. Dis Model Mech 6:1213-26
Bechmann, Lars P; Vetter, Diana; Ishida, Junichi et al. (2013) Post-transcriptional activation of PPAR alpha by KLF6 in hepatic steatosis. J Hepatol 58:1000-6
Hoshida, Yujin; Villanueva, Augusto; Sangiovanni, Angelo et al. (2013) Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis. Gastroenterology 144:1024-30
Garrido-Martín, Eva M; Blanco, Francisco J; Roquè, Mercé et al. (2013) Vascular injury triggers Krüppel-like factor 6 mobilization and cooperation with specificity protein 1 to promote endothelial activation through upregulation of the activin receptor-like kinase 1 gene. Circ Res 112:113-27
Ghiassi-Nejad, Zahra; Hernandez-Gea, Virginia; Woodrell, Christopher et al. (2013) Reduced hepatic stellate cell expression of Kruppel-like factor 6 tumor suppressor isoforms amplifies fibrosis during acute and chronic rodent liver injury. Hepatology 57:786-96

Showing the most recent 10 out of 106 publications